EP1268840A2 - Thauera strain mz1t exopolysaccharides - Google Patents
Thauera strain mz1t exopolysaccharidesInfo
- Publication number
- EP1268840A2 EP1268840A2 EP01926557A EP01926557A EP1268840A2 EP 1268840 A2 EP1268840 A2 EP 1268840A2 EP 01926557 A EP01926557 A EP 01926557A EP 01926557 A EP01926557 A EP 01926557A EP 1268840 A2 EP1268840 A2 EP 1268840A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- metal
- eps
- exopolysaccharide
- sample
- partially purified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229920002444 Exopolysaccharide Polymers 0.000 title claims abstract description 53
- 241001464942 Thauera Species 0.000 title claims description 34
- 229910052751 metal Inorganic materials 0.000 claims abstract description 78
- 239000002184 metal Substances 0.000 claims abstract description 78
- 238000000034 method Methods 0.000 claims abstract description 41
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims abstract description 23
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims abstract description 16
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims abstract description 13
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims abstract description 13
- XOCCAGJZGBCJME-IANFNVNHSA-N N-Acetyl-D-fucosamine Chemical compound C[C@H]1OC(O)[C@H](NC(C)=O)[C@@H](O)[C@H]1O XOCCAGJZGBCJME-IANFNVNHSA-N 0.000 claims abstract description 13
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims abstract description 10
- 239000008103 glucose Substances 0.000 claims abstract description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 8
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 claims abstract description 8
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 claims abstract description 8
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 claims abstract description 8
- 229950006780 n-acetylglucosamine Drugs 0.000 claims abstract description 8
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 5
- 229930182830 galactose Natural products 0.000 claims abstract description 5
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims abstract description 4
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 claims abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 229910001868 water Inorganic materials 0.000 claims description 27
- 239000006228 supernatant Substances 0.000 claims description 16
- 229910052770 Uranium Inorganic materials 0.000 claims description 14
- JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 claims description 14
- 238000012258 culturing Methods 0.000 claims description 8
- 238000000502 dialysis Methods 0.000 claims description 6
- 238000001542 size-exclusion chromatography Methods 0.000 claims description 3
- 150000002739 metals Chemical class 0.000 abstract description 11
- 241000571406 Thauera sp. Species 0.000 abstract description 3
- 150000004676 glycans Chemical class 0.000 description 21
- 229920001282 polysaccharide Polymers 0.000 description 21
- 239000005017 polysaccharide Substances 0.000 description 21
- 238000004458 analytical method Methods 0.000 description 20
- 239000000243 solution Substances 0.000 description 20
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 15
- 230000000813 microbial effect Effects 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 238000005084 2D-nuclear magnetic resonance Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 239000002244 precipitate Substances 0.000 description 10
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 239000002351 wastewater Substances 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 230000011987 methylation Effects 0.000 description 5
- 238000007069 methylation reaction Methods 0.000 description 5
- 150000008163 sugars Chemical class 0.000 description 5
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 239000001110 calcium chloride Substances 0.000 description 4
- 229910001628 calcium chloride Inorganic materials 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000013505 freshwater Substances 0.000 description 4
- 238000004817 gas chromatography Methods 0.000 description 4
- 238000004340 gradient COSY Methods 0.000 description 4
- 229960000367 inositol Drugs 0.000 description 4
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- 238000004065 wastewater treatment Methods 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000013522 chelant Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 125000003147 glycosyl group Chemical group 0.000 description 3
- 230000002906 microbiologic effect Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 3
- 229960001225 rifampicin Drugs 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000004566 IR spectroscopy Methods 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 229940034982 antineoplastic agent Drugs 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 230000009920 chelation Effects 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000002657 fibrous material Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000005189 flocculation Methods 0.000 description 2
- 230000016615 flocculation Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 238000005570 heteronuclear single quantum coherence Methods 0.000 description 2
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 2
- 230000000887 hydrating effect Effects 0.000 description 2
- 239000010842 industrial wastewater Substances 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- CZRYIXLKTDHMMY-YDKYIBAVSA-N n-[(2r,3r,4s,5r)-3,4,5-trihydroxy-1-oxohexan-2-yl]acetamide Chemical compound C[C@@H](O)[C@H](O)[C@H](O)[C@H](C=O)NC(C)=O CZRYIXLKTDHMMY-YDKYIBAVSA-N 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 239000012457 nonaqueous media Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000012354 sodium borodeuteride Substances 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 238000001551 total correlation spectroscopy Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 238000000411 transmission spectrum Methods 0.000 description 2
- -1 viscosity control Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 241000179442 Anacharis Species 0.000 description 1
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 235000000638 D-biotin Nutrition 0.000 description 1
- 239000011665 D-biotin Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 229910020350 Na2WO4 Inorganic materials 0.000 description 1
- 229910018890 NaMoO4 Inorganic materials 0.000 description 1
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920002310 Welan gum Polymers 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000009603 aerobic growth Effects 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 230000009604 anaerobic growth Effects 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229940054333 biotin 2 mg Drugs 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000007073 chemical hydrolysis Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000013580 millipore water Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229940037038 pantothenate 10 mg Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012465 retentate Substances 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Inorganic materials [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000004044 tetrasaccharides Chemical group 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 229910002007 uranyl nitrate Inorganic materials 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/68—Treatment of water, waste water, or sewage by addition of specified substances, e.g. trace elements, for ameliorating potable water
- C02F1/683—Treatment of water, waste water, or sewage by addition of specified substances, e.g. trace elements, for ameliorating potable water by addition of complex-forming compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22B—PRODUCTION AND REFINING OF METALS; PRETREATMENT OF RAW MATERIALS
- C22B60/00—Obtaining metals of atomic number 87 or higher, i.e. radioactive metals
- C22B60/02—Obtaining thorium, uranium, or other actinides
- C22B60/0204—Obtaining thorium, uranium, or other actinides obtaining uranium
- C22B60/0217—Obtaining thorium, uranium, or other actinides obtaining uranium by wet processes
- C22B60/0252—Obtaining thorium, uranium, or other actinides obtaining uranium by wet processes treatment or purification of solutions or of liquors or of slurries
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21F—PROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR
- G21F9/00—Treating radioactively contaminated material; Decontamination arrangements therefor
- G21F9/04—Treating liquids
- G21F9/06—Processing
- G21F9/10—Processing by flocculation
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/52—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
- C02F1/5236—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using inorganic agents
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/10—Inorganic compounds
- C02F2101/20—Heavy metals or heavy metal compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Definitions
- EPS extracellular polysaccharides
- complex polysaccharides such as microbial expolysaccharides have a variety of industrial applications. For example, many of these molecules have been used as thickeners in the food and cosmetic industries, adhesives, coating agents, freeze stabilizers, water soluble lubricants, for suspending waste fragments in drilling or cutting operations, and for reducing turbulence of fluid flow in pipelines and other containers. See, e.g., Baird et al., "Industrial Applications Of Some New Microbial Polysaccharides," Biotechnology, November 1983, pp. 778- 83; J.W.
- xanthan gum is produced by a gram-negative bacterium (Xanthomonas campestris), and is used as a thickener in many different compositions. See, e.g., Jeanes, et al., J. Appl. Polymer ScL, 5,519-526 (1961).
- useful bacterial exopolysaccharides include gellan (a microbial anionic heteropolysaccharide composed of tetrasaccharide units produced by Auromonas elodea ATCC 31461); S-88 (See, Kang and Veeder, U.S. Pat. No.
- the invention relates to a partially purified bacterial exopolysaccharide and a purified exopolysaccharide with a molecular weight of about 250 kD, termed "thaueran,” that were obtained from Thauera sp. Strain MZIT, an organism previously isolated from the wastewater treatment system of an industrial manufacturing plant.
- the present invention also provides an isolated exopolysaccharide, termed thaueran, produced from Thauera strain MZIT.
- This exopolysaccharide has a molecular weight of about 250 kDa and comprises rhamnose, galacturonic acid, N- acetylfucosamine and N-acetyl glucosamine.
- a method of removing metal from a sample comprising: a) contacting a metal containing sample with a partially purified EPS produced from Thauera strain MZIT; b) allowing a complex to form between the metal in the metal containing sample and the partially purified EPS; and c) removing the complex of step b) from the sample.
- Figure 6 is a chart showing the results obtained in a one dimensional 1H-NMR analysis of 250 kD thaueran exopolysaccharide.
- Figure 7 is a chart showing the results obtained in a two dimensional NMR analysis (gCOSY) of 250 kD thaueran exopolysaccharide.
- the present invention provides a partially pu ⁇ fied exopolysaccha ⁇ de (EPS) produced from Thauera strain MZIT.
- Monosaccha ⁇ de constituents of the partially punfied exopolysaccha ⁇ de include glucose, galacturonic acid, and N-acetylfucosamine in a ratio of approximately 4:2' 1.
- the partially pu ⁇ fied EPS contains the monosaccha ⁇ des rhamnose, xylose, and galactose in lower quantities Methylation analysis showed that the partially pu ⁇ fied EPS is highly branched having 1-3, 1-4, and 1-6 glycosyl linkages.
- MZIT produces a partially punfied EPS when grown on simple organic acids and related compounds commonly associated with indust ⁇ al wastewaters. After pu ⁇ fication, the partially punfied EPS appears as a white fibrous material with a cotton-like consistency.
- the partially purified EPS is readily soluble in water, but insoluble in most organic solvents and solubility is reduced above pH 7.
- the present invention also provides a method of producing the partially purified EPS from Thauera MZIT comprising the steps of: a) culturing the Thauera MZIT in media; and b) purifying the partially purified EPS produced from the Thauera MZIT culture of step a).
- Microorganism culturing techniques are well known in the art and the Examples included herein provide sufficient guidance for one of skill in the art to make the appropriate media, culture MZIT and recover the partially purified EPS of the present invention.
- MZIT can be grown in most non-selective, complex media including YEPG (Yeast extract, peptone, and glucose media). Stoke's medium can also be utilized.
- partially purified EPS is insoluble in organics (solvents, alcohols, etc.)
- a woven filter could be made to allow flow through metal extraction from solvents and solutions similar to the filter utilized to separate a metal-partially purified EPS precipitate from water.
- the partially purified EPS of this invention is similar to other bacterial polysaccharides that have been used in hydrating agents, stabilizing emulsions, gel formulation, viscosity control, foam stabilization, film formation, suspending agents, acoustical membranes, and structural fibers.
- the present invention also provides an isolated exopolysaccharide produced from Thauera strain MZIT, termed thaueran. More specifically, the invention provides an isolated exopolysaccharide produced from MZIT, wherein the exopolysaccharide has a molecular weight of about 250 kDa and comprises rhamnose, galacturonic acid, N-acetylfucosamine and N-acetyl glucosamine.
- Monosaccharide constituents include rhamnose (Rha), galacturonic acid (GalA), N-acetylfucosamine (2-acetamido-2, 6-dideoxy-galactose, FucNac) and N-acetyl glucosamine.
- Microorganism culturing techniques are well known in the art and the Examples included herein provide sufficient guidance for one of skill in the art to make the appropriate media, culture MZIT and recover the thaueran EPS of the present invention.
- thaueran EPS is specifically envisioned to be useful for removing metal ions from aqueous and non-aqueous solutions resulting from industrial processes or a waste stream.
- the thaueran EPS/wastewater is mixed to allow the dissolved thaueran EPS to bind metals present in the wastewater.
- a precipitating agent such as a calcium salt (CaCl 2 precipitates the thaueran EPS dissolved in aqueous solutions) or a base is then added to precipitate the thaueran EPS out of solution. This precipitate is separated from the water by, for example, allowing the precipitate to sediment to the bottom of the tank and removing the purified wastewater from the top of the tank.
- the precipitate can also be separated from the water by filtration.
- the metal -containing thauean EPS is then disposed.
- the thaueran EPS can be treated with an acid to free the bound metals, or the metals can be precipitated by reacting them with an anion (sulfate for example, depending on the metal of interest) and neutralizing pH to form insoluble metal salts. Free sugars resulting from these processes can be washed into the wastestream. It is also envisioned that heavy metals bound by the thaueran EPS could be exchanged with another metal so that the thaueran EPS could be safely reused.
- a woven filter could be made to allow flow through metal extraction from solvents and solutions similar to the filter utilized to separate a metal-thaueran EPS precipitate from water.
- the thaueran EPS of this invention is similar to other bacterial polysaccharides that have been used in hydrating agents, stabilizing emulsions, gel formulation, viscosity control, foam stabilization, film formation, suspending agents, acoustical membranes, and structural fibers.
- the thaueran EPS is therefore expected to be useful in one or more of these applications as well.
- thaueran EPS could be used commercially for food and cosmetic uses, oil extraction, as components of firefighting fluids, as wound dressings in eye and joint surgery, and as anti-tumor agents. See e.g.
- Thaueran EPS could be woven into a product that would dissolve in the presence of water.
- the solubility could be controlled (at least temporarily) by controlling the calcium concentration in the final product.
- Thaueran EPS might thus be useful for making cigarette filters that degrade in the environment to reduce pollution, or as line filters for solvents.
- Thaueran EPS could also be used for extraction of various substances from solvents or in a water bath to free up a material of interest.
- thaueran EPS N-acetylfucosamine (2-acetamido-2, 6-dideoxy-galactose, FucNac)
- FucNac N-acetylfucosamine
- Fucose containing oligosaccharides can be used to prevent tumor cell colonization of the lung, to control formation of white blood cells (anti-inflammatory effect) and to treat rheumatoid arthritis (Vanhooren and Vandamme "L-Fucose: Occurrence, physiological role, chemical, enzymatic and microbial synthesis” J. Chem Technol. Biotechnol. 74: 479-497 (1999). Fucose can also be used in the synthesis of antigens for antibody production and in cosmetics as a skin moisturizing agent. Since fucose production via chemical synthesis is laborious and suffers from low yield, fucose can be obtained from thaueran by chemical or enzymatic hydrolysis.
- Thauera defined medium which was used to culture growth was prepared as described below.
- a trace elements solution was prepared by mixing together the following:
- Partially purified EPS was also analyzed for carbohydrate content.
- a sample of partially purified EPS was hydrolyzed using freshly prepared IM methanolic-HCl for 16h at 80°C.
- the released sugars were derivatized with Tri-Sil and the samples were analyzed by Gas Chromatography (GC) using a Supelco column.
- GC Gas Chromatography
- Myo-inositol (20 ug) was also added as an internal standard. Results are shown in Table 1 below.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Environmental & Geological Engineering (AREA)
- General Health & Medical Sciences (AREA)
- Water Supply & Treatment (AREA)
- General Chemical & Material Sciences (AREA)
- High Energy & Nuclear Physics (AREA)
- Hydrology & Water Resources (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Geology (AREA)
- Manufacturing & Machinery (AREA)
- Materials Engineering (AREA)
- Mechanical Engineering (AREA)
- Metallurgy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides partially purified EPS that was purified from Thauera sp. Strain MZ1T. This partially purified EPS comprises rhamnose, xylose, galacturonic acid, galactose, glucose, N-acetylfucosamine. The invention further provides methods of producing the partially purified EPS and of utilizing the partially purified EPS in methods of chelating metals. Further provided by this invention is an exopolysaccharide termed 'thaueran' that was purified from Thauera sp. Strain MZ1T. This exopolysaccharide has a molecular weight of about 250 kDa and comprises rhamnose, galacturonic acid, N-acetylfucosamine and N-acetylglucosamine. The invention also provides methods of producing the exopolysaccharide and of utilizing the exopolysaccharide in methods of chelating metals.
Description
THAUERA STRAIN MZ1T EXOPOLYSACHHARIDES
This application claims priority from provisional patent application Serial No. 60/193,750, filed March 31, 2000, which is hereby incorporated in its entirety by this reference.
FIELD OF THE INVENTION
The invention relates to the field of polysaccharides. More particularly, the invention relates to a partially purified exopolysaccharide and a purified exopolysaccharide, termed thaueran, produced from a bacterial species. This invention also relates to methods of making and using these exopolysaccharides.
BACKGROUND
A number of microorganisms produced extracellular polysaccharides, also known as exopolysaccharides or EPS. Complex polysaccharides such as microbial expolysaccharides have a variety of industrial applications. For example, many of these molecules have been used as thickeners in the food and cosmetic industries, adhesives, coating agents, freeze stabilizers, water soluble lubricants, for suspending waste fragments in drilling or cutting operations, and for reducing turbulence of fluid flow in pipelines and other containers. See, e.g., Baird et al., "Industrial Applications Of Some New Microbial Polysaccharides," Biotechnology, November 1983, pp. 778- 83; J.W. Hoyt, Drag Reduction In Polysaccharide Solutions, Trends in Biotechnology, 3, 17-20 (1985); and G.R. Petersen et al. "Rheologically Interesting Polysaccharides From Yeasts", Appl. Biochem. Biotech., 20/21, 845-67 (1989). In other applications, complex polysaccharides have been used as anti-neoplastic agents, hypertension
controlling agents, wound healing agents, food coating agents and enzyme substrates. See, e.g. Sutherland, "Novel and established applications of microbial polysaccharides," Trends in Biotechnology 16, 41-46 (1998); Sutherland, "Industrially Useful Microbial Polysaccharides," Microbiological Sciences 3, 5-9 (1986) and Vanhooren and Vandamme, "L-Fucose: occurrence, physiological role, chemical, enzymatic and microbial synthesis," J. Chem Technol. Biotechnol. 74: 479-497 (1999).
Perhaps the most common example of a commercially useful microbial exopolysaccharide is xanthan gum. Xanthan gum is produced by a gram-negative bacterium (Xanthomonas campestris), and is used as a thickener in many different compositions. See, e.g., Jeanes, et al., J. Appl. Polymer ScL, 5,519-526 (1961). Other examples of useful bacterial exopolysaccharides include gellan (a microbial anionic heteropolysaccharide composed of tetrasaccharide units produced by Auromonas elodea ATCC 31461); S-88 (See, Kang and Veeder, U.S. Pat. No. 4,535,153); welan (See, Kang and Veeder, U.S. Pat. No. 4,342,866); NWl 1 (See, Robison and Stipanovic, U.S. Pat. No. 4,874,044); rhamsan (See, Peik, et al. Al., U.S. Pat. No. 4,401,760); S- 198 (See, Peik, et al. Al. U.S. Pat. No. 4,529,797); S-657 (See, Peik, et al., Eur. Patent Application 209277A1); and heteropolysaccharide-7 (See, Kang and McNeely, U.S. Pat. No. 4,342,866).
The invention relates to a partially purified bacterial exopolysaccharide and a purified exopolysaccharide with a molecular weight of about 250 kD, termed "thaueran," that were obtained from Thauera sp. Strain MZIT, an organism previously isolated from the wastewater treatment system of an industrial manufacturing plant.
SUMMARY OF THE INVENTION
The present invention provides a partially purified exopolysaccharide produced from Thauera strain MZIT, that comprises rhamnose, xylose, galacturonic acid,
galactose, glucose, N-acetylfucosamine and N-acetylglucosamine.
The present invention also provides an isolated exopolysaccharide, termed thaueran, produced from Thauera strain MZIT. This exopolysaccharide has a molecular weight of about 250 kDa and comprises rhamnose, galacturonic acid, N- acetylfucosamine and N-acetyl glucosamine.
Also provided by the present invention is a method of producing partially purified exopolysaccharide produced from Thauera strain MZIT comprising the steps of: a) culturing the Thauera MZIT in media; and b) purifying the exopolysaccharide produced from the Thauera MZIT culture of step a).
This invention further provides a method of producing thaueran EPS produced from Thauera strain MZIT comprising the steps of: a) culturing the Thauera MZIT in media; and b) purifying the thaueran EPS produced from the Thauera MZIT culture of step a).
Further provided by the present invention is a method of removing metal from a sample comprising: a) contacting a metal containing sample with a partially purified EPS produced from Thauera strain MZIT; b) allowing a complex to form between the metal in the metal containing sample and the partially purified EPS; and c) removing the complex of step b) from the sample.
Also provided by the present invention is a method of removing metal from a sample comprising: a) contacting a metal containing sample with thaueran EPS produced from Thauera strain MZIT; b) allowing a complex to form between the metal in the metal containing sample and the thaueran EPS; and c) removing the complex of step b) from the sample.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a chart showing results obtained in a one dimensional NMR analysis of partially purified exopolysaccharide.
Figure 2 is a chart showing results obtained in a two dimensional NMR analysis (gCOSY) of partially purified exopolysaccharide.
Figure 3 is a chart showing results obtained in a two dimensional NMR analysis (NOESY) of partially purified exopolysaccharide.
Figure 4 is a chart showing results obtained in an IR analysis of partially purified exopolysaccharide.
Figure 5 shows an IR transmittance spectrum for 250 kD thaueran exopolysaccharide.
Figure 6 is a chart showing the results obtained in a one dimensional 1H-NMR analysis of 250 kD thaueran exopolysaccharide.
Figure 7 is a chart showing the results obtained in a two dimensional NMR analysis (gCOSY) of 250 kD thaueran exopolysaccharide.
Figure 8 is a chart showing the results obtained in a two dimensional NMR analysis (TOCSY) of 250 kD thaueran exopolysaccharide.
Figure 9 is a chart showing the results obtained in a two dimensional NMR analysis (NOESY) of 250 kD thaueran exopolysaccharide.
Figure 10 is a chart showing the results obtained in a two dimensional I3C-Η NMR analysis (HSQC) of 250 kD thaueran exopolysacchaπde
DETAILED DESCRIPTION OF THE INVENTION
The present invention may be understood more readily by reference to the following detailed descπption of the preferred embodiments of the invention and the Examples included herein.
Before the present methods are disclosed and descπbed, it is to be understood that this invention is not limited to specific polysaccharides or specific methods It is also to be understood that the terminology used herein is for the purpose of descπbing particular embodiments only and is not intended to be limiting.
As used in the specification and the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise
The present invention provides a partially puπfied exopolysacchaπde (EPS) produced from Thauera strain MZIT. Monosacchaπde constituents of the partially punfied exopolysacchaπde include glucose, galacturonic acid, and N-acetylfucosamine in a ratio of approximately 4:2' 1. Additionally, the partially puπfied EPS contains the monosacchaπdes rhamnose, xylose, and galactose in lower quantities Methylation analysis showed that the partially puπfied EPS is highly branched having 1-3, 1-4, and 1-6 glycosyl linkages.
MZIT produces a partially punfied EPS when grown on simple organic acids and related compounds commonly associated with industπal wastewaters. After puπfication, the partially punfied EPS appears as a white fibrous material with a
cotton-like consistency. The partially purified EPS is readily soluble in water, but insoluble in most organic solvents and solubility is reduced above pH 7.
The present invention also provides a method of producing the partially purified EPS from Thauera MZIT comprising the steps of: a) culturing the Thauera MZIT in media; and b) purifying the partially purified EPS produced from the Thauera MZIT culture of step a). Microorganism culturing techniques are well known in the art and the Examples included herein provide sufficient guidance for one of skill in the art to make the appropriate media, culture MZIT and recover the partially purified EPS of the present invention. For example, MZIT can be grown in most non-selective, complex media including YEPG (Yeast extract, peptone, and glucose media). Stoke's medium can also be utilized.
In the method described above, the partially purified EPS can be purified by: a) centrifuging the Thauera MZIT culture; b) decanting the supernatant; c) concentrating the supernatant; d) dialyzing the supernatant against water using molecular weight cutoff dialysis; e) collecting the contents of the dialysis tubes.
Further provided by the present invention is a method of chelating a metal in a sample, comprising the steps of: a) contacting a metal containing sample with a partially purified EPS produced from Thauera strain MZIT and b) allowing a complex to form between the metal in the metal containing sample and the partially purified EPS, therefore chelating a metal in the sample.
The present invention also provides a method of removing metal from a sample comprising: a) contacting a metal containing sample with a partially purified EPS produced from Thauera strain MZIT; b) allowing a complex to form between the metal in the metal containing sample and the partially purified EPS; and c) removing the complex of step b) from the sample.
The metals that can be chelated and/or removed by these methods include, but are not limited to uranium, calcium, cadmium, copper and other positively charged metal cations.
Since the partially purified EPS is capable of chelating metals, it is specifically envisioned to be useful for removing metal ions from aqueous and non-aqueous solutions resulting from industrial processes or a waste stream. The partially purified EPS/wastewater is mixed to allow the dissolved partially purified EPS to bind metals present in the wastewater. A precipitating agent such as a calcium salt (CaCl2 precipitates the partially purified EPS dissolved in aqueous solutions) or a base is then added to precipitate the partially purified EPS out of solution. This precipitate is separated from the water by, for example, allowing the precipitate to sediment to the bottom of the tank and removing the purified wastewater from the top of the tank. The precipitate can also be separated from the water by filtration. The metal-containing partially purified EPS is then disposed. In some applications, the partially purified EPS can be treated with an acid to free the bound metals, or the metals can be precipitated by reacting them with an anion (sulfate for example, depending on the metal of interest) and neutralizing pH to form insoluble metal salts. Free sugars resulting from these processes can be washed into the wastestream. It is also envisioned that heavy metals bound by the partially purified EPS could be exchanged with another metal so that the partially purified EPS could be safely reused. Additionally, it is envisioned that because partially purified EPS is insoluble in organics (solvents, alcohols, etc.), a woven filter could be made to allow flow through metal extraction from solvents and solutions similar to the filter utilized to separate a metal-partially purified EPS precipitate from water. Given the polymeric nature of the partially purified exopolysaccharide, it is expected that it can be weaved and manipulated to generate cellulose based filters.
The partially purified EPS of this invention is similar to other bacterial polysaccharides that have been used in hydrating agents, stabilizing emulsions, gel formulation, viscosity control, foam stabilization, film formation, suspending agents, acoustical membranes, and structural fibers. The partially purified EPS is therefore expected to be useful in one or more of these applications as well. Given the similarity of partially purified EPS to other polysaccharides with known uses, it is specifically envisioned that partially purified EPS could be used commercially for food and cosmetic uses, oil extraction, as components of firefighting fluids, as wound dressings in eye and joint surgery, and as anti-tumor agents. See e.g. Sutherland, "Novel and established applications of microbial polysaccharides," Trends in Biotechnology 16, 41- 46 (1998); Sutherland, "Industrially Useful Microbial Polysaccharides," Microbiological Sciences 3, 5-9 (1986) and Vanhooren and Vandamme, "L-Fucose: occurrence, physiological role, chemical, enzymatic and microbial synthesis," J. Chem Technol. Biotechnol. 74: 479-497 (1999). This partially purified EPS is also useful as an agent for promoting flocculation in waste water treatment.
In addition, because of its fibrous nature, partially purified EPS could be woven into a product that would dissolve in the presence of water. The solubility could be controlled (at least temporarily) by controlling the calcium concentration in the final product. Partially purified EPS might thus be useful for making cigarette filters that degrade in the environment to reduce pollution, or as line filters for solvents. Partially purified EPS could also be used for extraction of various substances from solvents and transferred to an aqueous solution to dissolve the polymer and free up a material of interest.
The present invention also provides an isolated exopolysaccharide produced from Thauera strain MZIT, termed thaueran. More specifically, the invention provides an isolated exopolysaccharide produced from MZIT, wherein the exopolysaccharide
has a molecular weight of about 250 kDa and comprises rhamnose, galacturonic acid, N-acetylfucosamine and N-acetyl glucosamine.
Monosaccharide constituents include rhamnose (Rha), galacturonic acid (GalA), N-acetylfucosamine (2-acetamido-2, 6-dideoxy-galactose, FucNac) and N-acetyl glucosamine.
MZIT produces thaueran EPS when grown on simple organic acids and related compounds commonly associated with industrial wastewaters. After purification, the thaueran EPS appears as a white fibrous material with a cotton-like consistency. The thaueran EPS is readily soluble in water, but insoluble in most organic solvents and solubility is reduced above pH 7.
The present invention also provides a method of producing the thaueran EPS from Thauera MZIT comprising the steps of: a) culturing the Thauera MZIT in media; and b) purifying the thaueran EPS produced from the Thauera MZIT culture of step a).
Microorganism culturing techniques are well known in the art and the Examples included herein provide sufficient guidance for one of skill in the art to make the appropriate media, culture MZIT and recover the thaueran EPS of the present invention.
In the method described above, the thaueran EPS can be purified by: a) centrifuging the Thauera MZIT culture; b) decanting the supernatant; c) concentrating the supernatant; d) purifying the supernatant by size exclusion chromatography; e) collecting a thaueran EPS containing fraction produced by step (d), thus purifying the thaueran EPS.
Further provided by the present invention is a method of chelating a metal in a
sample, comprising the steps of: a) contacting a metal containing sample with thaueran EPS produced from Thauera strain MZIT and b) allowing a complex to form between the metal in the metal containing sample and the thaueran EPS, therefore chelating a metal in the sample.
The present invention also provides a method of removing metal from a sample comprising: a) contacting a metal containing sample with thaueran EPS produced from Thauera strain MZIT; b) allowing a complex to form between the metal in the metal containing sample and thauean EPS; and c) removing the complex of step b) from the sample.
The metals that can be chelated and/or removed by these methods include, but are not limited to uranium and a number of positively charged metal cations. See, e.g. Carol et al. Environ. Sci. Tech 33:3622-3626 (1999). Also, the presence of galacturonic acid allows thaueran EPS to bind positively charged substances and the presence of N- acetylfucosamine allows thaueran EPS to bind negatively charged substances. Therefore, thaueran EPS can be used to bind both positively and negatively charged substances.
Similar to the partially purified EPS, thaueran EPS is specifically envisioned to be useful for removing metal ions from aqueous and non-aqueous solutions resulting from industrial processes or a waste stream. The thaueran EPS/wastewater is mixed to allow the dissolved thaueran EPS to bind metals present in the wastewater. A precipitating agent such as a calcium salt (CaCl2 precipitates the thaueran EPS dissolved in aqueous solutions) or a base is then added to precipitate the thaueran EPS out of solution. This precipitate is separated from the water by, for example, allowing the precipitate to sediment to the bottom of the tank and removing the purified wastewater from the top of the tank. The precipitate can also be separated from the water by filtration. The metal -containing thauean EPS is then disposed. In some
applications, the thaueran EPS can be treated with an acid to free the bound metals, or the metals can be precipitated by reacting them with an anion (sulfate for example, depending on the metal of interest) and neutralizing pH to form insoluble metal salts. Free sugars resulting from these processes can be washed into the wastestream. It is also envisioned that heavy metals bound by the thaueran EPS could be exchanged with another metal so that the thaueran EPS could be safely reused. Additionally, it is envisioned that because thaueran EPS is insoluble in organics (solvents, alcohols, etc.), a woven filter could be made to allow flow through metal extraction from solvents and solutions similar to the filter utilized to separate a metal-thaueran EPS precipitate from water.
The thaueran EPS of this invention is similar to other bacterial polysaccharides that have been used in hydrating agents, stabilizing emulsions, gel formulation, viscosity control, foam stabilization, film formation, suspending agents, acoustical membranes, and structural fibers. The thaueran EPS is therefore expected to be useful in one or more of these applications as well. Given the similarity of thaueran EPS to other polysaccharides with known uses, it is specifically envisioned that thaueran EPS could be used commercially for food and cosmetic uses, oil extraction, as components of firefighting fluids, as wound dressings in eye and joint surgery, and as anti-tumor agents. See e.g. Sutherland, "Novel and established applications of microbial polysaccharides," Trends in Biotechnology 16, 41-46 (1998); Sutherland, "Industrially Useful Microbial Polysaccharides," Microbiological Sciences 3, 5-9 (1986) and Vanhooren and Vandamme, "L-Fucose: occurrence, physiological role, chemical, enzymatic and microbial synthesis," J. Chem Technol. Biotechnol. 74: 479-497 (1999). This thaueran EPS is also useful as an agent for promoting flocculation in waste water treatment.
In addition, because of its fibrous nature, thaueran EPS could be woven into a product that would dissolve in the presence of water. The solubility could be controlled
(at least temporarily) by controlling the calcium concentration in the final product. Thaueran EPS might thus be useful for making cigarette filters that degrade in the environment to reduce pollution, or as line filters for solvents. Thaueran EPS could also be used for extraction of various substances from solvents or in a water bath to free up a material of interest.
The presence of N-acetylfucosamine (2-acetamido-2, 6-dideoxy-galactose, FucNac) in thaueran makes thaueran EPS a valuable source of fucose. Since fucose is costly and difficult to synthesize, thaueran EPS represents a source material from which fucose can be obtained for numerous anti-neoplastic and hypoallergenic applications. Fucose containing oligosaccharides can be used to prevent tumor cell colonization of the lung, to control formation of white blood cells (anti-inflammatory effect) and to treat rheumatoid arthritis (Vanhooren and Vandamme "L-Fucose: Occurrence, physiological role, chemical, enzymatic and microbial synthesis" J. Chem Technol. Biotechnol. 74: 479-497 (1999). Fucose can also be used in the synthesis of antigens for antibody production and in cosmetics as a skin moisturizing agent. Since fucose production via chemical synthesis is laborious and suffers from low yield, fucose can be obtained from thaueran by chemical or enzymatic hydrolysis.
EXAMPLES
MZIT
MZIT is a floc-forming bacterium previously isolated from an industrial wastewater treatment plant as described in Lajoie et al, Water Environment Research, 72:56, 2000. MZIT has been deposited with the American Type Culture Collection as Accession number ATCC No. 202120.
Materials
Thauera defined medium (TDM) which was used to culture growth was prepared as described below.
A trace elements solution was prepared by mixing together the following:
FeSO4 «7H2O 2100 mg
Na2EDTA 5200 mg
H3BO3 30 mg
MnCl2 -4H2O 100 mg
CoCl2 '6^0 190 mg
NiCl2 •OHzO 24 mg
CuSO4 «5H2O 25 mg
ZnSO4 »7H2O 144 mg
NaMoO4 -2H20 36 mg
Add H2O to bring to 1000 ml
The pH of the resulting solution was adjusted to between 6.0 - 6.5 with NaOH A W (tungsten)-solution was prepared by mixing together the following: NaOH 200 mg Na2WO42H20 8 mg
Add H20 to bring to 1000 ml.
A Vitamin mixture was prepared by mixing together the following:
Sodium phosphate-buffer,
20 mM, pH = 7.1 200 ml p-aminobenzoic acid 8 mg
D(+)Biotin 2 mg
Nicotinic acid 20 mg
Ca-D(+)Pantothenate 10 mg
Pyridoxin-Hydrochloride 30 mg.
A Thiamin solution was prepared by mixing together the following:
Sodium phosphate-buffer,
25 mM, pH = 7.1 200 ml
Thiamine-Chloride-Dihydrochloride 200 mg.
A Vitamin B12-solution was prepared by mixing together the following:
add H2O 100 ml
Cyanocobalamine 5 mg
Nitrocellulose filters with a pore size of 0.2 μm were used for the sterile filtration of all vitamin solutions.
A Sodium bicarbonate solution (1 M) was prepared by mixing together the following: NaHC03 84 g
Add H2O to bring to 1000 ml
One liter of solution was autoclaved in a sealed screw top container.
Freshwater medium (for aerobic growth conditions) was prepared by mixing together the following:
NH4C1 0.3 g
KH2PO (monobasic) 0.5 g
MgSO47H2O 0.5 g
CaCl22H2O 0.1 g
Sodium succinate 5 g
Add H2O to bring to 1000 ml
(0.85 g NaN03 can be added for anaerobic growth conditions)
This freshwater medium was autoclaved in a 1.5 L bottle, which was then sealed with a screw cap.
After the freshwater medium in 1.5 L bottle medium cooled, TDM was made by adding the following sterile solutions to 1 L of the freshwater medium:
Trace element solution 1 ml
W-solution 1 ml
Sodium bicarbonate-solution (1M) 30 ml Vitamin mixture 1 ml Thiamin solution 1 ml
B12 solution 1 ml
Purification of Partially Purified EPS
Partially purified EPS was purified as described below. 1 L of TDM containing
100 mg/1 rifampicin was inoculated with 200 ul of frozen MZIT rifampicin resistant stock culture (a rif-resistant mutant of the wild type MZIT was generated by repeated plating and screening for growth on rif plates; wild type MZIT has also been used to prepare purified thaueran EPS in the same manner but without adding rifampicin to the medium). The inoculated medium was incubated at 30° C in a shaking incubator (160 rpm) for 7 days. After this time, the culture was centrifuged at 10,000 X g for 15 minutes to pellet the bacteria. The supernatant was decanted, collected, and then concentrated to approximately 200 ml by rotary evaporation at 45° C under reduced pressure. The concentrate was then dialyzed against 4L of water using 3500 Da
molecular weight cutoff (MWCO) dialysis tubes. The water was changed 7 times over 3 days (about every 6-10 hours). The contents of the dialysis tubes was then transferred to fresh falcon tubes, frozen at -80 degrees C for >1 h, and then lyophilized until dry (-3 days) to yield the partially purified EPS.
Characterization of the partially purified EPS
A sample of partially purified EPS was purified as described above and analyzed by conventional chemical analyses. In solubility experiments, partially purified EPS proved readily soluble in water at pHs below about 7. Partially purified EPS was less soluble at higher pHs. The solubility of partially purified EPS in other solvents was investigated. Partially purified EPS proved insoluble in DMSO, acetone, ethanol, methanol, hexane, and ethyl acetate. It was also noted that the addition of CaCl2 (0.25-0.3 M) caused partially purified EPS to precipitate out of aqueous solutions. In melting point analyses, partially purified EPS decomposed at temperatures above 205°C. In viscosity analyses, it was noted that aqueous solutions became more viscous as higher concentrations of partially purified EPS were added.
Partially purified EPS was also analyzed for carbohydrate content. A sample of partially purified EPS was hydrolyzed using freshly prepared IM methanolic-HCl for 16h at 80°C. The released sugars were derivatized with Tri-Sil and the samples were analyzed by Gas Chromatography (GC) using a Supelco column. Myo-inositol (20 ug) was also added as an internal standard. Results are shown in Table 1 below.
TABLE 1
Carbohydrate Residues Mole
Rhamnose 7.9
Xylose 1.3
Galacturonic acid 25.5
Galactose 3.4
Glucose 49.5
N-acetylfucosamine 12.3
The percentage of soluble carbohydrate in the same was calculated to be 24.9%. The sample contained about 50% glucose and GalA as its major components. The sample also contained an unusual sugar residue N-acetylfucosamine. Also contained in this partialy purified EPS sample was N-acetylglucosamine.
Glcosyl linkage was assessed by conventional techniques using methylation analysis-GC mass spectrometry. Briefly, a partially purified EPS sample was dissolved in DMSO three days prior to the methylation. It was stirred and sonicated with 50 μl of glycerol to facilitate dissolution in the DMSO. The sample was methylated by the Hakomori procedure and then reduced with superdeuteride for 3h at room temperature. The methylated sample was hydrolyzed with 2M TFA at 120°C for 2h, and then reduced using sodium borodeuteride. The reduced sample was acetylated by pyridine and acetic anhydride prior to GC-MS analysis. Myoinositol was also added to the sample prior to the reduction step.
Results of this analysis are shown below in Table 2:
TABLE 2
Carbohydrate Residues % present
Terminal glucose 2.8
4-xylose 10.6
3-glucose 18.0
3-galacturonic acid 17.7
6-glucose 47.0
4-galactose 3.9
Under the conditions of this experiment, rhamnose was not detected in the sample. This could be due to the high volatility of rhamnose residues that could either be t-rhamnose or 2-rhamnose. FucNac would also not be detected under these conditions. The results suggested that the partially purified EPS is highly branched having 1-3,1-4, and 1-6 glycosyl linkages.
The structure of partially purified EPS was also characterized using NMR spectroscopy and IR spectroscopy. FIG. 1 shows results obtained in a one dimensional NMR analysis. FIG. 2 shows results obtained in a two dimensional NMR analysis (gCOSY). FIG. 3 shows results obtained in a two dimensional NMR analysis (NOESY). And FG. 4 shows results obtained in an IR analysis.
Metal Chelation
Partially purified EPS was shown to chelate uranium (U) under a variety of conditions. In one experiment, uranium binding to partially purified EPS in water was examined. A U stock solution was prepared by dissolving 0.1 g UO2(NO3)2 in 50 ml millipore water (2000 ppm). In a separate container, 10 mg of purified partially purified EPS was dissolved in 1 ml of water. 1 ml of the U stock solution was added to the 1 ml partially purified EPS solution to form a mixture. The mixture was vortexed for 30 seconds, allowed to sit 10 minutes, and then added to a centrifugal filtration column (Millipore Biomax 30-50 Kda filtration column). In a parallel control run, a sample containing only 1 ml water and 1 ml of the U stock was treated in the same manner as the partially purified EPS containing mixture. The filter columns were then centrifuged at 3400 rpm (in a standard centrifuge) for 1 hr. 1.5 ml of the filtered liquid
in each sample was transferred into 10 ml of ReadySafe Scintillation cocktail, and the samples were analyzed for radioactivity using a scintilation counter. Table 3 shows the results from 4 runs in cpm.
TABLE 3
Control Partiallv Purified EPS Present
463.5 314
464.5 331
464.5 302
448.5 337.5
The results indicated that an average of 30.2% of the originally present uranium was bound by the polysaccharide.
In related experiments, the ability of partially purified EPS to chelate uranium dissolved in methanol was examined. A U stock solution was prepared by dissolving 0.1 g in 50 ml methanol. In each of several test tubes, 8 mg of partially purified EPS was added to 2 ml of the U stock solution to form a mixture (partially purified EPS does not dissolve in methanol). Control samples not containing partially purified EPS were run in parallel. These mixtures were placed in a 30 degree shaking incubator (160 rpm) for 2 hours, after which the tubes were centrifuged at 3000 rpm for 5 minutes to pellet the partially purified EPS. The supernatant was decanted and collected. 1.5 ml of the supernatant from each tube was added to 10 ml ReadySafe Scintillation Cocktail, and the same were analyzed for radioactivity using a scintillation counter. Table 4 shows the results of 6 runs in cpm (10 minutes of counting).
TABLE 4
Control Thaueran Present
22471 5207
22328 5207
22852 5411 22999 5570
21095 5532
20915 5476 avg.=22110 avg.=5400.5
The results indicated that an average of 75.6% of the originally present uranium was removed by the polysaccharide.
Other assays were performed to assess uranium-binding by purified thaueran exopolsaccharide in the presence of equimolar (to U) amounts of EDTA (commonly found in metal-containing waste streams). These experiments were performed using the centrifugation column protocol described above. The results indicated that an average of about 40% of the originally present uranium was bound by the polysaccharide.
Purification of thaueran EPS
One liter of seven-day-old MZIT culture grown in TDM was centrifuged at 8000 X g to pellet cells. The resultant cell-free supernatant was decanted and subsequently concentrated to one tenth of its original volume using a Millipore Pellicon 2 Mini Holder filtration apparatus equipped with a 100,000 Da MWCO filter. The retentate containing the thaueran EPS was then brought back to its original volume with deionized water and the process was repeated for a total of three times. The desalted EPS solution was then concentrated to approximately 100 ml, frozen at -70° C, and lyophilized to yield the crude polymer. Crude thaueran EPS was further purified by
size exclusion chromatography using a 1 m X 2.5 cm column packed with Bio-Gel P- 30 fine polyacrylamide gel (Bio-Rad) as per the manufacturer's instructions. The buffer used for all purification was 0.25 M ammonium formate. The buffer was degassed under vacuum and maintained in a reservoir sparged with nitrogen. Approximately 10 ml fractions were collected every hour using an ISCO Retriever III fraction collector. Peaks were detected with an in-line mounted ISCO UA-5 Absorbance/Fluorescence Detector with a 254 nm wavelength filter. Individual fractions were analyzed by spectrophotometry at 214 nm and samples absorbing at this wavelength were frozen and lyophilized to remove ammonium formate. All fraction-containing vials were washed with a total of 10 ml deionized water and the collected wash water was refrozen and lyophilized to concentrate the thaueran EPS.
The structure of thaueran EPS was also characterized using NMR spectroscopy and IR spectroscopy. Figure 5 shows an IR transmittance spectrum for 250 kD thaueran exopolysaccharide. Results obtained in a one dimensional 1H-NMR analysis of 250 kD thaueran exopolysaccharide are shown in Figure 6. Two dimensional NMR analysis (gCOSY) of 250 kD thaueran exopolysaccharide is shown in Figure 7. Figure 8 is a chart showing the results obtained in a two dimensional NMR analysis (TOCSY) of 250 kD thaueran exopolysaccharide. Figure 9 is a chart showing the results obtained in a two dimensional NMR analysis (NOESY) of 250 kD thaueran exopolysaccharide. Figure 10 is a chart showing the results obtained in a two dimensional 13C-1H NMR analysis (HSQC) of 250 kD thaueran exopolysaccharide.
Carbohydrate content of thaueran EPS is analyzed as described above for partially purified EPS. A sample of thaueran EPS is hydrolyzed using freshly prepared IM methanolic-HCl for 16h at 80°C. The released sugars are derivatized with Tri-Sil and the samples are analyzed by Gas Chromatography (GC) using a Supelco column. Myo-inositol (20 ug) is also added as an internal standard. Glycosyl
linkage for thaueran EPS is assessed, as described above for partially purified EPS, by conventional techniques using methylation analysis-GC mass spectrometry. Briefly, a thaueran EPS sample is dissolved in DMSO three days prior to the methylation. It is stirred and sonicated with 50 μl of glycerol to facilitate dissolution in the DMSO. The sample is methylated by the Hakomori procedure and then reduced with super deuteride for 3h at room temperature. The methylated sample is hydrolyzed with 2M TFA at 120°C for 2h, and then reduced using sodium borodeuteride. The reduced sample was acetylated by pyridine and acetic anhydride prior to GC-MS analysis. Myoinositol is also added to the sample prior to the reduction step.
Metal chelation experiments for thaueran EPS are performed as described above for partially purified EPS. Due to the presence of metal chelating sugars on thaueran EPS, this exopolysaccharide is expected to have metal chelating properties, such as the ability to chelate uranium.
Although the present process has been described with reference to specific details of certain embodiments thereof, it is not intended that such details should be regarded as limitations upon the scope of the invention except as and to the extent that they are included in the accompanying claims.
Throughout this application, various publications are referenced. The disclosures of these publications in their entireties, as well as the references cited in these publications, are hereby incorporated by reference into this application in order to more fully describe the state of the art to which this invention pertains.
Claims
1. An isolated exopolysaccharide produced from Thauera strain MZIT.
2. The exopolysaccharide of claim 1 wherein the exopolysaccharide is a partially purified EPS and comprises rhamnose, xylose, galacturonic acid, galactose, glucose, N-acetylfucosamine and N-acetylglucosamine.
3. The exopolysaccharide of claim 1, wherein the exopolysaccharide has a molecular weight of about 250 kDa and comprises rhamnose, galacturonic acid, N-acetylfucosamine and N-acetylglucosamine.
4. A method of producing the exopolysaccharide of claim 2 comprising the steps of: a) culturing the Thauera MZIT in medium; and b) purifying the partially purified EPS produced from the Thauera MZIT culture of step a).
5. The method of claim 4, wherein the partially purified EPS is purified by:
a) centrifuging the Thauera MZIT culture; b) decanting the supernatant; c) concentrating the supernatant; d) dialyzing the supernatant against water using molecular weight cutoff dialysis tubes. e) collecting the contents of the dialysis tubes.
6. A method of removing a metal from a sample comprising: a) contacting a metal containing sample with the partially purified EPS of claim 2; b) allowing a complex to form between the metal in the metal containing sample and the partially purified EPS; and c) removing the complex of step b) from the sample, thus removing the metal from the sample.
7. The method of claim 5, wherein the metal is uranium.
8. A method of chelating a metal in a sample, comprising the steps of:
a) contacting a metal containing sample with the partially purified EPS of claim 2; and b) allowing a complex to form between the metal in the metal containing sample and the partially purified EPS, thus chelating a metal in the sample.
9. The method of claim 7, wherein the metal is uranium.
10. A method of producing the exopolysaccharide of claim 3 comprising the steps of:
a) culturing the Thauera MZIT in medium; and b) purifying the exopolysaccharide produced from the Thauera MZIT culture of step a).
11. The method of claim 10, wherein the exopolysaccharide is purified by:
a) centrifuging the Thauera MZIT culture; b) decanting the supernatant; c) concentrating the supernatant; d) purifying the supernatant by size exclusion chromatography; e) collecting an exopolysaccharide containing fraction produced from step (d), thus purifying the exopolysaccharide.
12. A method of removing a metal from a sample comprising:
a) contacting a metal containing sample with the exopolysaccharide of claim 3; b) allowing a complex to form between the metal in the metal containing sample and the exopolysaccharide; and c) removing the complex of step b) from the sample, thus removing the metal from the sample.
13. The method of claim 12, wherein the metal is uranium.
14. A method of chelating a metal in a sample, comprising the steps of:
a) contacting a metal containing sample with the exopolysaccharide of claim 3; and b) allowing a complex to form between the metal in the metal containing sample and the exopolysaccharide, thus chelating a metal in the sample.
15. The method of claim 7, wherein the metal is uranium.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19375000P | 2000-03-31 | 2000-03-31 | |
| US193750P | 2000-03-31 | ||
| PCT/US2001/010657 WO2001075138A2 (en) | 2000-03-31 | 2001-04-02 | Thauera strain mz1t exopolysachharides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1268840A2 true EP1268840A2 (en) | 2003-01-02 |
Family
ID=22714854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP01926557A Withdrawn EP1268840A2 (en) | 2000-03-31 | 2001-04-02 | Thauera strain mz1t exopolysaccharides |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1268840A2 (en) |
| AU (1) | AU2001253087A1 (en) |
| WO (1) | WO2001075138A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2012000047A1 (en) * | 2012-01-06 | 2012-07-20 | Cultivos Hidrobiologicos Y Biotecnologia Aguamarina S A | Method for reducing particulate matter suspended in air or water, which comprises agglomerating the particulate matter suspended with negatively charged exopolysaccharides (eps). |
| CL2012000241A1 (en) * | 2012-01-30 | 2012-08-10 | Cultivos Hidrobiologicos Y Biotecnologia Aguamarina S A | Composition to reduce particulate material suspended in air or a liquid comprising a source of exopolysaccharides (eps), a strain of microorganisms with ureolytic activity and a culture medium; method of reducing particulate matter suspended in air or a liquid comprising applying said composition. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988000948A1 (en) * | 1986-07-28 | 1988-02-11 | Massachusetts Institute Of Technology | Method to control and produce novel biopolymers |
| US4948733A (en) * | 1986-07-28 | 1990-08-14 | Massachusetts Institute Of Technology | Zoogloea transformation using exopoly saccharide non-capsule producing strains |
| US5118803A (en) * | 1990-09-13 | 1992-06-02 | Wisconsin Alumni Research Foundation | Zooglan polysaccharide |
| US6124094A (en) * | 1997-10-17 | 2000-09-26 | Eastman Chemical Company | Zoogloeal and hyphomicrobium spp. nucleic acids |
-
2001
- 2001-04-02 WO PCT/US2001/010657 patent/WO2001075138A2/en not_active Ceased
- 2001-04-02 AU AU2001253087A patent/AU2001253087A1/en not_active Abandoned
- 2001-04-02 EP EP01926557A patent/EP1268840A2/en not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| See references of WO0175138A2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001075138A3 (en) | 2002-03-14 |
| AU2001253087A1 (en) | 2001-10-15 |
| WO2001075138A2 (en) | 2001-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Morillo et al. | Production of a metal-binding exopolysaccharide by Paenibacillus jamilae using two-phase olive-mill waste as fermentation substrate | |
| AU600888B2 (en) | Method of producing high molecular weight sodium hyaluronate by fermentation of streptococcus | |
| Vincent et al. | Production and characterization of an exopolysaccharide excreted by a deep-sea hydrothermal vent bacterium isolated from the polychaete annelid Alvinella pompejana | |
| CA2732234C (en) | Process for the co-production of chitin, its derivatives and polymers containing glucose, mannose and/or galactose, by the fermentation of the yeast pichia pastoris | |
| CN102839138A (en) | Marine bacterium pseudoalteromonas issachenkonii HZ and polysaccharide produced by same | |
| CN112358985B (en) | Pradazobium and application thereof in preparation of water-soluble beta-1, 3 glucan | |
| Li et al. | Application of exopolysaccharides synthesized by Xanthomonas campestris in an efficient separation system of refractory chalcopyrite and molybdenite | |
| JP4441304B2 (en) | Method for preparing water-soluble low-viscosity β-D-glucan-containing culture solution | |
| CN113755407B (en) | Paenibacillus mucilaginosus, extracellular polysaccharide prepared by same and application of extracellular polysaccharide in preparation of microbial flocculant | |
| WO2001075138A2 (en) | Thauera strain mz1t exopolysachharides | |
| Sar et al. | Fish skin bacteria: production of friction-reducing polymers | |
| EP1283896B1 (en) | Method for obtaining a polysaccharide substantially free from whole cells and cell debris | |
| Guo et al. | New extraction technology and characterization of sodium alginate | |
| US20040030120A1 (en) | Thauera strain mz1t exopolysachharides | |
| CN101676307A (en) | Method for purifying sodium hyaluronate | |
| EP0979301B1 (en) | Pseudomonas alginovora strain producing alginate-lyase and its use for the depolymerisation of alginate | |
| CN116037322A (en) | A kind of biosynthetic flotation agent and its preparation method and application | |
| Tomulescu et al. | Isolation and partial characterization of a poly-saccharide produced by Klebsiella oxytoca ICCF 419, a newly-isolated strain in Romania | |
| CN119367390B (en) | Application of myrtle polysaccharide P5 in preparation of antibacterial and antioxidant drugs | |
| JPH0549491A (en) | Method for producing polysaccharides from fine algae | |
| JP3741734B2 (en) | Xanthan gum recovery and purification method | |
| JP3797851B2 (en) | Method for producing chitin / chitosan-like substance by bacteria | |
| WO2021136882A1 (en) | Animal free chitosan and methods and uses related thereto | |
| JP2620030B2 (en) | Method for producing oligosaccharide having β1 → 6 linkage | |
| Farres et al. | A simple and efficient method for the purification of an exopolysaccharide from Klebsiella sp. I-714 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20021025 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| 17Q | First examination report despatched |
Effective date: 20040521 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20041001 |